The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care

Diabet Med. 2022 Jun;39(6):e14788. doi: 10.1111/dme.14788. Epub 2022 Feb 27.

Abstract

This article summarises the Joint British Diabetes Societies for Inpatient Care guidelines on the management of ketoacidosis; available at https://abcd.care/resource/management-diabetic-ketoacidosis-dka-adults. The document explicitly states that when a person aged 16-18 is under the care of the paediatric team, then the paediatric guideline should be used, and if they are cared for by an adult team, then this guideline should be used. The guideline takes into account new evidence on the use of the previous version of this document, particularly the high prevalence of hypoglycaemia and hypokalaemia, and recommends that when the glucose concentration drops below 14 mmol/L, that de-escalating the insulin infusion rate from 0.1 to 0.05 units/kg/h should be considered. Furthermore, a section has been added to address the recognition that use of sodium glucose co-transporter 2 inhibitors is associated with an increased risk of euglycaemic ketoacidosis. The management of ketoacidosis in people with end-stage renal failure or on dialysis is also mentioned. Finally, the algorithms to illustrate the guideline have been updated.

Keywords: diabetic ketoacidosis; guideline; management.

MeSH terms

  • Adult
  • Child
  • Diabetes Mellitus*
  • Diabetic Ketoacidosis* / epidemiology
  • Diabetic Ketoacidosis* / therapy
  • Glucose
  • Hospitalization
  • Humans
  • Inpatients
  • Insulin / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Insulin
  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucose